AU2002212107A1 - New multimeric interferon beta polypeptides - Google Patents

New multimeric interferon beta polypeptides

Info

Publication number
AU2002212107A1
AU2002212107A1 AU2002212107A AU1210702A AU2002212107A1 AU 2002212107 A1 AU2002212107 A1 AU 2002212107A1 AU 2002212107 A AU2002212107 A AU 2002212107A AU 1210702 A AU1210702 A AU 1210702A AU 2002212107 A1 AU2002212107 A1 AU 2002212107A1
Authority
AU
Australia
Prior art keywords
interferon beta
beta polypeptides
multimeric
new
new multimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212107A
Inventor
Kim Vilbour Andersen
Claus Bornaes
Anders Hjelholt Pedersen
Paul Baad Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxygen ApS
Original Assignee
Maxygen ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen ApS filed Critical Maxygen ApS
Publication of AU2002212107A1 publication Critical patent/AU2002212107A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2002212107A 2000-11-02 2001-11-01 New multimeric interferon beta polypeptides Abandoned AU2002212107A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001646 2000-11-02
DKPA200001646 2000-11-02
PCT/DK2001/000723 WO2002036628A2 (en) 2000-11-02 2001-11-01 New multimeric interferon beta polypeptides

Publications (1)

Publication Number Publication Date
AU2002212107A1 true AU2002212107A1 (en) 2002-05-15

Family

ID=8159820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212107A Abandoned AU2002212107A1 (en) 2000-11-02 2001-11-01 New multimeric interferon beta polypeptides

Country Status (3)

Country Link
EP (1) EP1334128A2 (en)
AU (1) AU2002212107A1 (en)
WO (1) WO2002036628A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003254641A1 (en) * 2002-08-28 2004-03-19 Maxygen Aps Interferon beta-like molecules for treatment of cancer
AU2003277006C1 (en) * 2002-09-27 2010-04-01 Biogen Idec Ma Inc. Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta
FR2851471B1 (en) * 2003-02-24 2006-07-28 Synt Em COMPOUNDS COMPRISING AT LEAST ONE ACTIVE SUBSTANCE AND AT LEAST ONE VECTOR CONNECTED BY A BINDING AGENT, USES THEREOF AND THE BINDING AGENTS
BRPI0507169A (en) * 2004-02-02 2007-06-26 Ambrx Inc modified human growth hormone polypeptides and their uses
GB0405634D0 (en) 2004-03-12 2004-04-21 Univ Southampton Anti-virus therapy for respiratory diseases
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0237019A3 (en) * 1986-03-14 1988-03-09 Toray Industries, Inc. Interferon conjugate and production thereof using recombinant gene
US5919758A (en) * 1994-03-22 1999-07-06 Beth Israel Deaconess Medical Center Modified polypeptides with altered biological activity
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US6187564B1 (en) * 1997-07-10 2001-02-13 Beth Israel Deaconess Medical Center DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
EP1881005B1 (en) * 1997-07-14 2013-04-03 Bolder Biotechnology, Inc. Derivatives of G-CSF and related proteins
DK1656952T3 (en) * 1998-10-16 2014-01-20 Biogen Idec Inc Polyalkylene glycol conjugates of interferon beta-1A and applications thereof
IL142350A0 (en) * 1998-10-16 2002-03-10 Biogen Inc Interferon-beta fusion proteins and pharmaceutical compositions containing the same
SK2942002A3 (en) * 1999-08-27 2002-08-06 Maxygen Aps A conjugate exhibiting interferon beta, a nucleotide sequence, an expressing vector, a host cell containing such a nucleotide sequence, method for the preparation thereof, pharmaceutical composition containing the same and its use

Also Published As

Publication number Publication date
EP1334128A2 (en) 2003-08-13
WO2002036628A3 (en) 2003-01-03
WO2002036628A2 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
SG85204A1 (en) Sintered materials
AU2705201A (en) Ceramic structure
AU6045900A (en) Interaction-activated proteins
AU5617900A (en) Chimeric chemokine-antigen polypeptides and uses therefor
AU2002212108A1 (en) Single-chain multimeric polypeptides
GB9921125D0 (en) Proteins
EP1412499A4 (en) Cytokine polypeptides
AU2002212107A1 (en) New multimeric interferon beta polypeptides
AU2002241899A1 (en) Tip39 polypeptides
AU2001288220A1 (en) Hyperglycosylated polypeptides
AU7049601A (en) Ceramic material
GB9903430D0 (en) Novel proteins
AU6983000A (en) Chimeric proteins
AU5491900A (en) Glycoprotein hormone family member
AU4778600A (en) Novel polypeptide
AU6712600A (en) Polypeptides
AU1686701A (en) Dispatched polypeptides
AU2002240889A1 (en) Proteins that interact with betatrcp
GB0125093D0 (en) Multimeric proteins
AU2002224056A1 (en) Novel polypeptide
AU6444600A (en) New protein
AU3242200A (en) Pyk2 binding proteins
EP1152059A4 (en) Novel cytokine recfptor-like protein
GB9923932D0 (en) Multimeric proteins
AU4853301A (en) Genetic factor affecting cytokine expression